Concepedia

Author

Pierre Quartier

Hôpital Necker-Enfants MaladesORCID

Also Known As

Arsène Mekinian, Aurora Pujol, Cyril Gitiaux, Frederic Rieux-Laucat, H Brunner, Inmaculada Calvo Penades, Johan Provot, K. L. Hyrich, Kiran Nistala, M Gattorno

561

Publications

22.4K

Citations

78

H-Index

131

Concepts

All Affiliations

Hôpital Necker-Enfants MaladesUniversité Paris CitéAssistance Publique – Hôpitaux de ParisInsermIstituto Giannina Gaslini
PQ

About

Pierre Quartier is an author at Hôpital Necker-Enfants Malades specializing in medicine, immunology, and autoimmunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

45

5.5K

2

Allergy

6

6

1.2K

3

Cell Biology

5

5

723

4

Health Sciences

3

3

362

5

Public Health

1

1

78

Pierre Quartier

×

165

Publications

19.6K

Citations

73

H-Index

YearCitations

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Helen J. Lachmann, Isabelle Koné‐Paut, Jasmin Kuemmerle‐Deschner,

New England Journal of Medicine

2009

842

Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and Chondrocytes

Jérôme Feldmann, Anne‐Marie Prieur, Pierre Quartier,

The American Journal of Human Genetics

2002

738

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier,

New England Journal of Medicine

2012

689

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier,

The Lancet

2008

543

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Pierre Quartier, Florence Allantaz, Rolando Cimaz,

Annals of the Rheumatic Diseases

2010

543

Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency

Bertrand Boisson, Emmanuel Laplantine, Carolina Prando,

Nature Immunology

2012

460

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

Fabrizio De Benedetti, Marco Gattorno, Jordi Antón,

New England Journal of Medicine

2018

458

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

Benjamin Terrier, Zahir Amoura, Philippe Ravaud,

Arthritis & Rheumatism

2010

407

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

Thierry Lequerré, Pierre Quartier, David Rosellini,

Annals of the Rheumatic Diseases

2007

403

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Nöel Milpied, B. Vasseur, Nathalie Parquet,

Annals of Oncology

2000

376

Page 1